PTC Therapeutics, Inc. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
PTC Therapeutics, Inc. (PTCT) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$8.03 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2020-08-05
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2020-06-30 was -$8.03M, a 818.98% decline year-over-year.
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2020-03-31 was $8.60M.
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-12-31 was -$11.20M.
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-09-30 was -$1.31M.
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2019 was -$12.05M.
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2018 was -$2.51M, a 145.97% decline from fiscal 2017.
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2017 was $5.45M.
- PTC Therapeutics, Inc. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2016 was -$285.00K.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2020-06-30 | -$8.03M 10-Q · filed 2020-08-05 | $568.00K 10-Q · filed 2020-08-05 | -$10.63M derived: sum of 3 quarters · filed 2020-08-05 | -$11.94M derived: sum of 4 quarters · filed 2020-08-05 | |
| 2020-03-31 | $8.60M 10-Q · filed 2020-04-30 | -$2.60M derived: sum of 2 quarters · filed 2020-04-30 | -$3.91M derived: sum of 3 quarters · filed 2020-04-30 | -$2.79M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2019-12-31 | -$11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$12.51M derived: sum of 2 quarters · filed 2020-03-02 | -$11.39M derived: sum of 3 quarters · filed 2020-03-02 | -$12.05M 10-K · filed 2020-03-02 | |
| 2019-09-30 | -$1.31M 10-Q · filed 2019-10-30 | -$189.00K derived: sum of 2 quarters · filed 2019-10-30 | -$846.00K 10-Q · filed 2019-10-30 | -$1.01M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-06-30 | $1.12M 10-Q · filed 2019-08-06 | $460.00K 10-Q · filed 2019-08-06 | $294.00K derived: sum of 3 quarters · filed 2020-03-02 | $67.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-03-31 | -$657.00K 10-Q · filed 2019-05-02 | -$823.00K derived: sum of 2 quarters · filed 2020-03-02 | -$1.05M derived: sum of 3 quarters · filed 2020-03-02 | -$4.15M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-12-31 | -$166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$393.00K derived: sum of 2 quarters · filed 2020-03-02 | -$3.49M derived: sum of 3 quarters · filed 2020-03-02 | -$2.51M 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$227.00K 10-Q · filed 2018-11-05 | -$3.33M derived: sum of 2 quarters · filed 2018-11-05 | -$2.34M 10-Q · filed 2018-11-05 | -$1.39M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | -$3.10M 10-Q · filed 2018-08-07 | -$2.11M 10-Q · filed 2018-08-07 | -$1.16M derived: sum of 3 quarters · filed 2020-03-02 | -$144.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $984.00K 10-Q · filed 2018-05-09 | $1.94M derived: sum of 2 quarters · filed 2020-03-02 | $2.95M derived: sum of 3 quarters · filed 2020-03-02 | $5.83M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $956.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.97M derived: sum of 2 quarters · filed 2020-03-02 | $4.84M derived: sum of 3 quarters · filed 2020-03-02 | $5.45M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $1.01M 10-Q · filed 2017-11-02 | $3.89M derived: sum of 2 quarters · filed 2017-11-02 | $4.50M 10-Q · filed 2017-11-02 | $2.26M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $2.88M 10-Q · filed 2017-08-09 | $3.48M 10-Q · filed 2017-08-09 | $1.24M derived: sum of 3 quarters · filed 2019-03-01 | $1.11M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $609.00K 10-Q · filed 2017-05-08 | -$1.63M derived: sum of 2 quarters · filed 2019-03-01 | -$1.76M derived: sum of 3 quarters · filed 2019-03-01 | ||
| 2016-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$2.37M derived: sum of 2 quarters · filed 2019-03-01 | -$285.00K 10-K · filed 2019-03-01 | ||
| 2016-09-30 | -$129.00K 10-Q · filed 2016-11-03 | $1.96M 10-Q · filed 2016-11-03 | |||
| 2016-03-31 | $2.28M 10-Q · filed 2016-05-05 | $2.21M derived: sum of 2 quarters · filed 2018-03-06 | $1.58M derived: sum of 3 quarters · filed 2018-03-06 | $1.82M derived: sum of 4 quarters · filed 2018-03-06 | |
| 2015-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$705.00K derived: sum of 2 quarters · filed 2018-03-06 | -$464.00K derived: sum of 3 quarters · filed 2018-03-06 | -$463.00K 10-K · filed 2018-03-06 | |
| 2015-09-30 | -$632.00K 10-Q · filed 2015-11-09 | -$391.00K derived: sum of 2 quarters · filed 2015-11-09 | -$390.00K 10-Q · filed 2015-11-09 | -$1.06M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2015-06-30 | $241.00K 10-Q · filed 2015-07-31 | $242.00K 10-Q · filed 2015-07-31 | -$426.00K derived: sum of 3 quarters · filed 2016-02-29 | -$585.00K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2015-03-31 | $1.00K 10-Q · filed 2015-05-05 | -$667.00K derived: sum of 2 quarters · filed 2016-02-29 | -$826.00K derived: sum of 3 quarters · filed 2016-02-29 | -$816.00K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-12-31 | -$668.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$827.00K derived: sum of 2 quarters · filed 2016-02-29 | -$817.00K derived: sum of 3 quarters · filed 2016-02-29 | -$807.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | -$159.00K 10-Q · filed 2014-11-06 | -$149.00K derived: sum of 2 quarters · filed 2014-11-06 | -$139.00K 10-Q · filed 2014-11-06 | -$28.53K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $10.00K 10-Q · filed 2014-08-07 | $20.00K 10-Q · filed 2014-08-07 | $130.47K derived: sum of 3 quarters · filed 2016-02-29 | $90.77K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $10.00K 10-Q · filed 2014-05-06 | $120.47K derived: sum of 2 quarters · filed 2016-02-29 | $80.77K derived: sum of 3 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $110.47K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $70.77K derived: sum of 2 quarters · filed 2016-02-29 | $70.00K 10-K · filed 2016-02-29 | $70.39K 10-K · filed 2014-03-06 | |
| 2013-09-30 | -$39.70K 10-Q · filed 2013-11-14 | -$40.47K 10-Q · filed 2013-11-14 | |||
| 2011-12-31 | -$3.61K 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |